Drugmaker Eli Lilly announced promising Phase 3 study results for its new GLP-1 pill.Orforglipron is a drug similar to ...

Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...

A daily weight loss pill being tested by Eli Lilly could work as well as its GLP-1 injection counterparts like Ozempic, ...

Eli Lilly reported promising results from a study of its experimental oral drug that could rival popular injections to treat ...

A new weight-loss pill taken daily could compete with injections like Ozempic, research suggests. Patients, who all were ...

The prospect of a pill rather than an injection is obviously appealing to some people, but will fear of needles be enough to ...

Diabetics given the pill called orforglipron lost 16 pounds, or 7.9% of their body weight, over a 40-week period.

But the popular injection is seeing new competition with Mounjaro, and now a daily pill which could help patients lose 16 ...

A “game-changing” Ozempic-style daily pill could transform public health in Britain, experts have said. The drug is expected ...

Previous studies found people injected with semaglutide, the active ingredient in Wegovy ... pills over injections.’ Side effects on the tablet were similar to the weight-loss injections ...

Wegovy – a modified version of type 2 diabetes drug Ozempic – and Mounjaro are the leading weight loss injections used in the UK. Wegovy, real name semaglutide, has been used on the NHS for ...